Effect of nintedanib in patients with systemic sclerosis-associated interstitial lung disease and risk factors for rapid progression

By sjmartinez • February 17, 2023

Khanna D, Maher TM, Volkmann ER, Allanore Y, Smith V, Assassi S, Kreuter M, Hoffmann-Vold AM, Kuwana M, Stock C, Alves M, Sambevski S, Denton CP. Effect of nintedanib in patients with systemic sclerosis-associated interstitial lung disease and risk factors for rapid progression. RMD Open. 2023 Feb;9(1):e002859. doi: 10.1136/rmdopen-2022-002859. PMID: 36796874; PMCID: PMC9936273.

Tags: Autoimmune Diseases, Publications, Pulmonary fibrosis, Rheumatology, Scleroderma, Systemic, Therapeutics

Hybrid Transcatheter Pulmonary Valve Replacement With SAPIEN S3 Following Right Ventricular Outflow Tract Reduction Using Tricuspid Annuloplasty Rings

Chandavimol M, Samankatiwat P, Limsuwan A, Ngernsritrakul T, Aboulhosn J. Hybrid Transcatheter Pulmonary Valve Replacement With SAPIEN S3 Following Right Ventricular Outflow Tract Reduction Using[...]

Alcohol-Attributable Cancer: Update From the Global Burden of Disease 2021 Study

Danpanichkul P, Pang Y, Díaz LA, White TM, Sirimangklanurak S, Auttapracha T, Suparan K, Syn N, Jatupornpakdee P, Saowapa S, Ng CH, Kaewdech A, Lui[...]

Domestic violence laws and women’s unmet need for family planning: Quasi-experimental evidence from Africa

Bhuwania P, Raub A, Sprague A, Martin A, Bose B, Kidman R, Heymann J. Domestic violence laws and women's unmet need for family planning: Quasi-experimental[...]